The director of the Allegheny Multiple Sclerosis Treatment Center at Allegheny General Hospital discussed exploring the potential role of BTK inhibitors and advanced MRI techniques to address smoldering multiple sclerosis. [WATCH TIME: 10 minutes]
Thomas F. Scott, MD
Advertisement
Director of the Allegheny Multiple Sclerosis Treatment Center at Allegheny General Hospital.
Articles by Thomas F. Scott, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles
2
US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic
3
Overviewing Promising Phase 1/2 Data of Gene Therapy ETX101 in Dravet Syndrome: Joseph Sullivan, MD
4
AES Poster Lays Insights Into EEG and MRI Biomarkers of MOGAD-Related Epilepsy
5
